DIANTHUS THERAPEUTICS INC (DNTH) Stock Balance Sheet
NASDAQ:DNTH - US2528281080 - Common Stock
23.57 USD
-1.24 (-5%)
23.57 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 13.24M | 22.79M | 132.32M | 57.60M | 131.70M | |||
| Marketable Securities | 244.15M | 252.45M | 41.39M | 54.40M | 45.30M | |||
| Receivables | 39.00K | 807.00K | 478.00K | N/A | N/A | |||
| Other Current Assets | 6.18M | 4.86M | 3.25M | 3.60M | 3.80M | |||
| Total Current Assets | 263.61M | 280.90M | 177.45M | 115.60M | 180.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.58M | 1.75M | 800.00K | 29.30M | 7.50M | |||
| Investments And Advances | 51.70M | 81.73M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 9.18M | 9.63M | 1.15M | 1.80M | 1.80M | |||
| Total Non-Current Assets | 62.47M | 93.10M | 1.95M | 31.00M | 9.20M | |||
| TOTAL ASSETS | 326.08M | 374.01M | 179.41M | 146.60M | 189.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 14.21M | 13.39M | 6.92M | 12.10M | 7.30M | |||
| Accounts Payable | 5.40M | 4.58M | 2.61M | 2.50M | 3.00M | |||
| Other Current Liabilities | 479.00K | 479.00K | 100.00K | 0.00 | 600.00K | |||
| Total Current Liabilities | 20.09M | 18.45M | 9.63M | 14.50M | 10.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 2.90M | 3.08M | 904.00K | 26.10M | 6.40M | |||
| Total Non-Current Liabilities | 2.90M | 3.08M | 904.00K | 26.20M | 6.40M | |||
| TOTAL LIABILITIES | 23.00M | 21.53M | 10.54M | 40.70M | 17.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -235.53M | -174.39M | -89.42M | -402.00M | -325.60M | |||
| Additional Paid In Capital | 538.48M | 526.73M | 258.23M | 508.10M | 498.20M | |||
| Common Shares | 32.00K | 31.00K | 15.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | 98.00K | 106.00K | 47.00K | -200.00K | 0.00 | |||
| Shares Outstanding | 32.18M | 31.12M | 14.82M | 3.80M | 3.70M | |||
| Tangible Book Value per Share | 9.42 | 11.33 | 11.40 | 27.89 | 46.68 | |||
| Total Shareholders' Equity | 303.08M | 352.48M | 168.87M | 106.00M | 172.70M | |||
| TOTAL LIABILITIES AND EQUITY | 326.08M | 374.01M | 179.41M | 146.60M | 189.90M | |||
| Statistics | ||||||||
| Current Ratio | 13.12 | 15.22 | 18.42 | 7.97 | 16.58 | |||
| Return On Assets (ROA) | -35.19% | -22.72% | -24.28% | -52.16% | -37.46% | |||
| Return On Equity (ROE) | -37.86% | -24.11% | -25.79% | -72.13% | -41.19% | |||
All data in USD , ROIC based on taxRate of 0.21